
Aerie Pharmaceuticals AERI
Quarterly report 2022-Q3
added 12-23-2023
Aerie Pharmaceuticals Operating Cycle 2011-2026 | AERI
Annual Operating Cycle Aerie Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 576 | 554 | 1.28 K | 2.9 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.9 K | 554 | 1.33 K |
Quarterly Operating Cycle Aerie Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 745 | - | 544 | 613 | 580 | 207 | 593 | 528 | 521 | 142 | 1.12 K | 2.95 K | 3.9 K | 17.1 | 4.54 K | 15.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.7 K | 17.1 | 2.18 K |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | ||
|
Canopy Growth Corporation
CGC
|
230 | $ 1.26 | -1.94 % | $ 136 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
425 | $ 2.67 | 0.57 % | $ 1.42 B | ||
|
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | ||
|
Catalent
CTLT
|
152 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M | ||
|
Emergent BioSolutions
EBS
|
237 | $ 13.18 | -1.35 % | $ 675 M | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
416 | $ 21.49 | 0.05 % | $ 2.04 B | ||
|
Evolus
EOLS
|
104 | $ 5.5 | -4.12 % | $ 341 M | ||
|
Harrow Health
HROW
|
102 | $ 49.05 | -3.9 % | $ 1.6 B | ||
|
China Pharma Holdings
CPHI
|
198 | $ 1.31 | -3.32 % | $ 22.9 M | ||
|
Jupiter Wellness
JUPW
|
194 | - | - | $ 33.6 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.72 | -0.41 % | $ 402 M | ||
|
Organogenesis Holdings
ORGO
|
159 | $ 4.18 | -0.83 % | $ 550 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 7.79 | 0.13 % | $ 2.84 B | ||
|
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
182 | $ 3.77 | -0.28 % | $ 4.68 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
614 | $ 4.77 | -1.24 % | $ 67.1 M | ||
|
Tilray
TLRY
|
222 | $ 9.42 | 3.14 % | $ 5.82 B | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 4.3 | 0.59 % | $ 86.3 M | ||
|
Veru
VERU
|
271 | $ 2.39 | 3.46 % | $ 322 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 22.6 | -13.16 % | $ 1.05 B | ||
|
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | ||
|
cbdMD
YCBD
|
176 | $ 1.04 | -3.7 % | $ 4.49 M | ||
|
Perrigo Company plc
PRGO
|
201 | $ 14.85 | 0.99 % | $ 2.04 B | ||
|
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | ||
|
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | ||
|
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | ||
|
Rockwell Medical
RMTI
|
65.9 | $ 0.96 | -2.11 % | $ 22.4 M | ||
|
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
459 | $ 9.25 | -0.64 % | $ 657 M | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
106 | $ 0.66 | -0.66 % | $ 31.6 M | ||
|
TherapeuticsMD
TXMD
|
3.34 K | $ 2.03 | -1.46 % | $ 21.2 M | ||
|
Viatris
VTRS
|
219 | $ 12.66 | 0.46 % | $ 15.3 B | ||
|
Zomedica Corp.
ZOM
|
196 | - | -0.21 % | $ 98 M |